Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary disease

References

• Chinese Society of Aspiration of Chinese Medical Association. Guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease (2013 revision). Chinese Tuberculosis Respiratory J. 2013;36(4):255–64.
   Google Scholar
• GOLD Executive Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2017 report). http://www.goldcopd.com
   Google Scholar
• Zhou MG, Wang HD, Zeng XY, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, et al. Mortality, morbidity, and risk factors in China and its provinces,1990-2017: asystematic analysis for the global burden of disease study 2017. The Lancet. 2019;394(10204):1145–58. doi:10.1016/S0140-6736(19)30427-1.
   PubMed Web of Science ®Google Scholar
• Fang LW, Gao P, Bao HL, Tang X, Wang B, Feng Y, Cong S, Juan J, Fan J, Lu K, et al. Chronic pulmonary disease in China: a national prevalence study. Lancet Respir Med. 2018;6(6):421–30. doi:10.1016/S2213-2600(18)30103-6.
   PubMed Web of Science ®Google Scholar
• Wang C, Xu JY, Yang L, Xu Y, Zhang X, Bai C, Kang J, Ran P, Shen H, Wen F, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH]study): a national cross-sectional study. The Lancet. 2018;391(10131):1706–17. doi:10.1016/S0140-6736(18)30841-9.
   PubMed Web of Science ®Google Scholar
• Expert group on diagnosis and treatment of acute exacerbation of chronic obstructive pulmonary disease. Chinese expert consensus on diagnosis and treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (2017 update). International Respiratory Journal. 2017;37(14):1041–55.
   Google Scholar
• CDC. Prevention and control of seasonal influenza with vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2009;58(RR08):1–52.
   PubMedGoogle Scholar
• Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination. Chest. 2004;125(6):2011–20. doi:10.1378/chest.125.6.2011.
   PubMed Web of Science ®Google Scholar
• Yerkovich ST, Hales BJ, Carroll ML, Burel JG, Towers MA, Smith DJ, Thomas WR, Upham JW. Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation. BMC Pulm Med. 2012;12:37. doi:10.1186/1471-2466-12-37.
   PubMed Web of Science ®Google Scholar
• Qin YF, Qi X, Li L, Zu RQ, Wu B, Fu JG, et al. Study on tendency of antibodies levels of influenza A (H1N1) vaccine inoculated population in Jiangsu Province. Chinese Journal of Disease Control & Prevention. 2011;15(9):773–76.
   Google Scholar
• Center for Biologics Evaluation and Research (CBER). Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines, Food and Drug Administration (FDA); 2007 [accessed December 25, 2020.] https://www.fda.gov/media/73691/download
   Google Scholar
• Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonisation of requirements for influenza vaccines. The European Agency for the Evaluation of Medicinal Products; 1997[accessed December 25, 2020] https://www.ema.europa.eu/en/documents/scientific-guideline/note-guidance-harmonisation-requirements-influenza-vaccines_en.pdf
   Google Scholar
• Bekkat-Berkani R, Wilkinson T, Buchy P, Dos Santos G, Stefanidis D, Devaster J-M, Meyer N. Seasonal influenza vaccination in patients with COPD: a systematic literature review. BMC Pulm Med. 2017;17(1):79. doi:10.1186/s12890-017-0420-8.
   PubMed Web of Science ®Google Scholar
• Chuaychoo B, Wongsurakiat P, Nana A, Kositanont U, Maranetra KN. The immunogenicity of intradermal influenza vaccination in COPD patients. Vaccine. 2010;28(24):4045–51. doi:10.1016/j.vaccine.2010.04.006.
   PubMed Web of Science ®Google Scholar
• Gorse GJ, O’Connor TZ, Newman FK, Mandava MD, Mendelman PM, Wittes J, Peduzzi PN. Immunity to influenza in older adults with chronic obstructive pulmonary disease. J Infect Dis. 2004;190:11–19. doi:10.1086/421121.
   PubMed Web of Science ®Google Scholar
• Gorse GJ, Otto EE, Daughaday CC, Newman FK, Eickhoff CS, Powers DC, Lusk RH. Influenza virus vaccination of patients with chronic lung disease. Chest. 1997;112:1221–33. doi:10.1378/chest.112.5.1221.
   PubMed Web of Science ®Google Scholar
• Nath KD, Burel JG, Shankar V, Pritchard AL, Towers M, Looke D, Davies JM, Upham JW. Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:51–56. doi:10.2147/COPD.S53590.
   PubMed Web of Science ®Google Scholar
• Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest. 2004;125:2011–20.
   PubMed Web of Science ®Google Scholar
• Poole P, Chacko E, Wood-Baker R, Cates C. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 1:2006;CD002733.
   PubMed Web of Science ®Google Scholar
• Nichol K, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999;130:397. doi:10.7326/0003-4819-130-5-199903020-00003.
   PubMed Web of Science ®Google Scholar
• Sehatzadeh S. Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review. Ont Health Technol Assess Ser. 2012;12:1–64.
   Google Scholar
• Wu JF, Chen YZ, Shen JJ, Shao RB, Wang Jin. Observation on the immune effect of split influenza vaccine. Chinese J Health Laboratory Technol. 2008;18(3):510–11.
   Google Scholar
• Wang P, Zhang XW, Song YF, Yin H-B, Liu L-J, Che L, Li H, Liu Y, Chen J-T. Safety and immunogenicity on the formulation of trivalent split influenza vaccine among healthy people aged over 18 years. Chinese Journal of Epidemiology. 2011;32:120–24.
   Google Scholar
• Luo FJ, Yang LQ, Ai X, Bai YH, Wu J, Li SM, Zhang Z, Lu M, Li L, Wang ZY, et al. Immunogenicity and safety of three 2010-2011 seasonal trivalent influenza vaccines in Chinese toddlers, children and older adults: a double-blind and randomized trial. Hum Vaccin Immunother. 2013 Aug;9(8):1725–34. doi:10.4161/hv.24832.
   PubMed Web of Science ®Google Scholar
• Sanei F, Wilkinson T. Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness. Ther Adv Respir Dis. 2016;10(4):349–67. doi:10.1177/1753465816646050.
   PubMed Web of Science ®Google Scholar